BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11488075)

  • 1. Cell biology and matrix biochemistry of chondromyxoid fibroma.
    Söder S; Inwards C; Müller S; Kirchner T; Aigner T
    Am J Clin Pathol; 2001 Aug; 116(2):271-7. PubMed ID: 11488075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm.
    Aigner T; Loos S; Inwards C; Perris R; Perissinotto D; Unni KK; Kirchner T
    J Pathol; 1999 Dec; 189(4):463-9. PubMed ID: 10629544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
    Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
    Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development.
    Gottschalk D; Fehn M; Patt S; Saeger W; Kirchner T; Aigner T
    Am J Pathol; 2001 May; 158(5):1571-8. PubMed ID: 11337353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone.
    Konishi E; Nakashima Y; Iwasa Y; Nakao R; Yanagisawa A
    Hum Pathol; 2010 Feb; 41(2):208-13. PubMed ID: 19801163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of collagen type II, S100B, S100A2 and osteocalcin in chondroblastoma and chondromyxoid fibroma.
    Park HR; Park YK; Jang KT; Unni KK
    Oncol Rep; 2002; 9(5):1087-91. PubMed ID: 12168078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondromyxoid fibroma: a tumor showing myofibroblastic, myochondroblastic, and chondrocytic differentiation.
    Nielsen GP; Keel SB; Dickersin GR; Selig MK; Bhan AK; Rosenberg AE
    Mod Pathol; 1999 May; 12(5):514-7. PubMed ID: 10349990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracranial chondromyxoid fibroma. Report of a case and review of the literature.
    Wolf DA; Chaljub G; Maggio W; Gelman BB
    Arch Pathol Lab Med; 1997 Jun; 121(6):626-30. PubMed ID: 9199632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Matrix gene expression pattern as indicators of the biology of cartilage-forming tumors].
    Aigner T; Unni CC; Bjornsson J; Kirchner T
    Verh Dtsch Ges Pathol; 1998; 82():178-83. PubMed ID: 10095430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas.
    Aigner T; Loos S; Müller S; Sandell LJ; Unni KK; Kirchner T
    Am J Pathol; 2000 Apr; 156(4):1327-35. PubMed ID: 10751358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pericentromeric inversion, inv (6)(p25q13), is a novel diagnostic marker in chondromyxoid fibroma.
    Granter SR; Renshaw AA; Kozakewich HP; Fletcher JA
    Mod Pathol; 1998 Nov; 11(11):1071-4. PubMed ID: 9831204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACTH enhances chondrogenesis in multipotential progenitor cells and matrix production in chondrocytes.
    Evans JF; Niu QT; Canas JA; Shen CL; Aloia JF; Yeh JK
    Bone; 2004 Jul; 35(1):96-107. PubMed ID: 15207745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of mesenchymal stem cell and chondrocyte differentiation by MIA.
    Tscheudschilsuren G; Bosserhoff AK; Schlegel J; Vollmer D; Anton A; Alt V; Schnettler R; Brandt J; Proetzel G
    Exp Cell Res; 2006 Jan; 312(1):63-72. PubMed ID: 16256983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characterisation and differentiation of chondroblastomas and chondromyxoidfibromas - presence and expression of collagen types I and II].
    Schörle CM; Inwards C; Unni KK; Kirchner T; Aigner T
    Z Orthop Ihre Grenzgeb; 2002; 140(2):208-13. PubMed ID: 12029596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression of types I, II, and VI collagen, aggrecan, and chondroitin-6-sulfotransferase in the human annulus: in situ hybridization findings.
    Gruber HE; Ingram J; Leslie K; Hanley EN
    Spine J; 2008; 8(5):810-7. PubMed ID: 18024225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.
    Bosnakovski D; Mizuno M; Kim G; Takagi S; Okumura M; Fujinaga T
    Biotechnol Bioeng; 2006 Apr; 93(6):1152-63. PubMed ID: 16470881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondromyxoid fibroma resembles in vitro chondrogenesis, but differs in expression of signalling molecules.
    Romeo S; Bovée JV; Grogan SP; Taminiau AH; Eilers PH; Cleton-Jansen AM; Mainil-Varlet P; Hogendoorn PC
    J Pathol; 2005 Jun; 206(2):135-42. PubMed ID: 15880456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells.
    Nöth U; Osyczka AM; Tuli R; Hickok NJ; Danielson KG; Tuan RS
    J Orthop Res; 2002 Sep; 20(5):1060-9. PubMed ID: 12382974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro expression of cartilage-specific markers by chondrocytes on a biocompatible hydrogel: implications for engineering cartilage tissue.
    Risbud M; Ringe J; Bhonde R; Sittinger M
    Cell Transplant; 2001; 10(8):755-63. PubMed ID: 11814119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identity of proliferating cells in bone tumors with cartilaginous components: evaluation by double-immunohistochemical staining using proliferating cell nuclear antigen and S-100 protein.
    Chano T; Ishizawa M; Matsumoto K; Morimoto S; Hukuda S; Okabe H
    Eur J Histochem; 1995; 39(1):21-30. PubMed ID: 7612954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.